{"created":"2023-07-27T06:29:17.529586+00:00","id":14045,"links":{},"metadata":{"_buckets":{"deposit":"390ca972-60cc-4859-a426-2bb03e212c17"},"_deposit":{"created_by":3,"id":"14045","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"14045"},"status":"published"},"_oai":{"id":"oai:kanazawa-u.repo.nii.ac.jp:00014045","sets":["1132:1133:1134"]},"author_link":["929","62","613","330","118","23891"],"item_4_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2014-01-01","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"2","bibliographicPageEnd":"205","bibliographicPageStart":"201","bibliographicVolumeNumber":"18","bibliographic_titles":[{"bibliographic_title":"Clinical and Experimental Nephrology"}]}]},"item_4_creator_33":{"attribute_name":"著者別表示","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"清水, 美保"}],"nameIdentifiers":[{},{},{}]},{"creatorNames":[{"creatorName":"古市, 賢吾"}],"nameIdentifiers":[{},{},{},{}]},{"creatorNames":[{"creatorName":"金子, 周一"}],"nameIdentifiers":[{},{},{},{}]},{"creatorNames":[{"creatorName":"和田, 隆志"}],"nameIdentifiers":[{},{},{},{}]}]},"item_4_description_21":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Recent epidemiological research revealed that dyslipidemia is a risk factor for development and progression of diabetic nephropathy. Results from interventional studies revealed the possibility that anti-hyperlipidemic agents have a better effect on diabetic nephropathy through improvement of albuminuria and loss of renal function. In addition, dyslipidemia may be a consequence of albuminuria and renal dysfunction, thereby perpetuating kidney damage. Today, the proportion of diabetic patients receiving statins is increasing due to their beneficial effect on cardiovascular mortality. However, treatment for patients should be determined based on consideration of the risk and benefit of the treatment. More insight into the pathogenesis of diabetic nephropathy and the effects of life-style changes is required. © 2013 Japanese Society of Nephrology.","subitem_description_type":"Abstract"}]},"item_4_identifier_registration":{"attribute_name":"ID登録","attribute_value_mlt":[{"subitem_identifier_reg_text":"10.24517/00014032","subitem_identifier_reg_type":"JaLC"}]},"item_4_publisher_17":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Japanese Society of Nephrology (JSN) 日本腎臓学会 / Springer Verlag (Germany)"}]},"item_4_relation_12":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1007/s10157-013-0898-1","subitem_relation_type_select":"DOI"}}]},"item_4_rights_23":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"The final publication is available at www.springerlink.com;http://link.springer.com/article/10.1007%2Fs10157-013-0898-1"}]},"item_4_source_id_11":{"attribute_name":"NCID","attribute_value_mlt":[{"subitem_source_identifier":"AA11126935","subitem_source_identifier_type":"NCID"}]},"item_4_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"1342-1751","subitem_source_identifier_type":"ISSN"}]},"item_4_version_type_25":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Toyama, Tadashi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Shimizu, Miho"}],"nameIdentifiers":[{},{},{}]},{"creatorNames":[{"creatorName":"Furuichi, Kengo"}],"nameIdentifiers":[{},{},{},{}]},{"creatorNames":[{"creatorName":"Kaneko, Shuichi"}],"nameIdentifiers":[{},{},{}]},{"creatorNames":[{"creatorName":"Wada, Takashi"}],"nameIdentifiers":[{},{},{},{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-10-03"}],"displaytype":"detail","filename":"ME-PR-WADA-T-201.pdf","filesize":[{"value":"164.2 kB"}],"format":"application/pdf","licensetype":"license_11","mimetype":"application/pdf","url":{"label":"ME-PR-WADA-T-201.pdf","url":"https://kanazawa-u.repo.nii.ac.jp/record/14045/files/ME-PR-WADA-T-201.pdf"},"version_id":"b30f7505-0dd2-4b2c-9375-4f7f7a0c5ee8"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Treatment and impact of dyslipidemia in diabetic nephropathy","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Treatment and impact of dyslipidemia in diabetic nephropathy"}]},"item_type_id":"4","owner":"3","path":["1134"],"pubdate":{"attribute_name":"公開日","attribute_value":"2017-10-03"},"publish_date":"2017-10-03","publish_status":"0","recid":"14045","relation_version_is_last":true,"title":["Treatment and impact of dyslipidemia in diabetic nephropathy"],"weko_creator_id":"3","weko_shared_id":3},"updated":"2023-07-27T17:30:34.948142+00:00"}